MetaCap

Radiopharm Theranostics (RADX) News

NASDAQ: RADXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.6304-0.0678 (-9.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RADX news summary

We found 5 recent headlines mentioning Radiopharm Theranostics (RADX): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. RADX is making an outsized move today, down 9.71% at $0.6304, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Radiopharm Theranostics Limited - Depositary Receipt Price Target Increased by 10.97% to $14.67", was published by Nasdaq on Nov 8, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Radiopharm Theranostics headlines

Stocks mentioned alongside RADX

Compare RADX